Frustration Drives Japan To Allow Generics Before Side Patents Expire
This article was originally published in PharmAsia News
TOKYO - In a continuing effort to raise generic drug use, Japan's Ministry of Health, Labor and Welfare has decided to allow generic drugs to be manufactured even before brand drugs' side patents expire, the ministry's Insurance Bureau officials said
You may also be interested in...
TOKYO - A wide data gap on generics penetration between studies commissioned by Chuikyo and the Ministry of Health, Labor and Welfare has surfaced, casting clouds over the Japanese government's official target to raise generics use to 30 percent by 2012
[Editor's note: This is part two of a two-part feature on obstacles in promoting generics in Japan. Part one, which explored negative connotations associated with with the term "generic," appeared in PharmAsia News, March 19, 2009.]
TOKYO - Manufacturers would take "certain degrees of action" to lower national health insurance listed prices if generic penetration failed to reach a certain level in the same composite group during a drug's patented period, according to an industry proposal during the latest Chuikyo pharmaceutical price expert subcommittee meeting March 18